Alfred Sandrock
President and CEO at Voyager Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Voyager Therapeutics Inc., 3 years.
Voyager Therapeutics Inc.
Director · President and CEO
Chief executive roles
Voyager Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 2, 2026 | Voyager Therapeutics Inc. | Open-market sale | −11,511 | $3.87 | $44,548 |
| Feb 24, 2026 | Voyager Therapeutics Inc. | Open-market sale | −14,197 | $3.79 | $53,807 |
| Feb 18, 2026 | Voyager Therapeutics Inc. | Open-market sale | −11,732 | $3.41 | $40,006 |
| Feb 10, 2026 | Voyager Therapeutics Inc. | Open-market sale | −12,192 | $3.78 | $46,086 |
| Feb 6, 2026 | Voyager Therapeutics Inc. | Grant or award | +86,250 | — | — |
| Apr 2, 2025 | Voyager Therapeutics Inc. | Open-market sale | −10,885 | $3.43 | $37,336 |
| Feb 21, 2025 | Voyager Therapeutics Inc. | Grant or award | +145,000 | — | — |
| Feb 20, 2025 | Voyager Therapeutics Inc. | Open-market sale | −11,702 | $4.24 | $49,616 |
| Feb 11, 2025 | Voyager Therapeutics Inc. | Open-market sale | −16,644 | $4.45 | $74,066 |
| Apr 2, 2024 | Voyager Therapeutics Inc. | Open-market sale | −12,115 | $9.86 | $119,454 |
| Feb 21, 2024 | Voyager Therapeutics Inc. | Open-market sale | −13,033 | $7.46 | $97,226 |
| Feb 9, 2024 | Voyager Therapeutics Inc. | Grant or award | +130,000 | — | — |
| Apr 3, 2023 | Voyager Therapeutics Inc. | Open-market sale | −7,437 | $7.83 | $58,232 |
| Feb 17, 2023 | Voyager Therapeutics Inc. | Grant or award | +120,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.